Category: Drug Safety Alerts
-
Lemtrada Review By European Drug Regulatory Agency Covers Various Serious Side Effects In MS Patients
EMA Will Investigate Reports Of Associated Conditions Beyond Those That Were In November 2018 FDA Drug Safety Communication (Posted by Tom Lamb at DrugInjuryWatch.com) We recently learned by means of this April…
-
Gadolinium Contrast Agents Side Effects: Medical Literature Review, September 2018 – February 2019
Researchers Continue To Investigate Gadolinium Deposition Disease (GDD) Following Gadolinium-Based Contrast Agents Injections (Posted by Tom Lamb at DrugInjuryWatch.com) In recent years it has been recognized that the gadolinium contained in certain…
-
Xeljanz Recommended Dosage For Ulcerative Colitis Patients May Increase Risk Of Pulmonary Embolism
FDA Is Reviewing Safety Of Xeljanz 10 mg Twice-Daily Dose Of This JAK Inhibitor, According to February 2019 News Reports (Posted by Tom Lamb at DrugInjuryWatch.com) UPDATE: FDA Drug Safety Communication: "Safety…
-
Januvia, Onglyza, Other Diabetes Drugs In DPP-4 Inhibitor Class Significantly Increase Risk Of Crohn’s Disease (CD)
But Same Medical Study Finds That DPP-4 Inhibitors Do Not Increase Risk Of Inflammatory Bowel Disease (IBD) (Posted by Tom Lamb at DrugInjuryWatch.com) Back in March 2018 we wrote this report, “Januvia,…
-
Diabetes Drugs In DPP-4 Inhibitor Class Associated With Almost Two-Times Increased Risk Of Cholangiocarcinoma
Medical Researchers Finding This Rare But Highly Fatal Cancer Call For More Investigation Into New Possible Drug Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) A recent medical study shows that the…
-
Lemtrada: Warnings About Strokes And Arterial Dissections / Blood Vessel Lining Damage Added To Drug Label
Symptoms Developed Within Just One Day Of Lemtrada Injections, And Can Lead To Patient Death Or Permanent Disability Says FDA (Posted by Tom Lamb at DrugInjuryWatch.com) In late November 2018 this FDA…
-
Farxiga And Jardiance Are Associated With Twofold Increased Risk For Lower Limb Amputations
November 2018: The BMJ Medical Journal Publishes New SGLT2 Diabetes Drug Observational Study (Posted by Tom Lamb at DrugInjuryWatch.com) Diabetes drugs in the sodium-glucose cotransporter 2 (SGLT2) inhibitors class are associated with…
-
CoaguChek XS PT Test Strips: Roche Devices For Blood Thinner INR Measurement – Urgent FDA Recall November 2018
More Than 1 Million Packages Of Defective Devices Used To Check INR For Warfarin May Cause Serious Injuries Or Death (Posted by Tom Lamb at DrugInjuryWatch.com) In September 2018 Roche Diagnostics issued…
-
Amputations Are SGLT-2 Inhibitors Drug-Class Side Effects It Now Appears, According To New Medical Evidence
Earlier Invokana Lower Limb Amputation Reports Are Being Followed By Farxiga And Jardiance Amputation Cases Now (Posted by Tom Lamb at DrugInjuryWatch.com) There is new medical evidence which suggests the hypovolemic effect…